BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HS-10522 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HS-10522\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07609875-565@assetmemo.bio
DTSTAMP:20261121T005824Z
DTSTART;VALUE=DATE:20270120
DTEND;VALUE=DATE:20270121
SUMMARY:HS-10522: Phase 1 readout est. (NCT07609875)
DESCRIPTION:HS-10522\, phase 1\, Hypertension.\nStudy: A Phase I Single and
  Multiple Dose Study to Evaluate the Safety\, Pharmacokinetics\, and Pharm
 acodynamics of HS-10522 in Healthy Chinese Participants and Chinese Partic
 ipants With Mild Hypertension\nEstimated primary completion: 20 January 20
 27. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/hs-10522#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07609875
URL:https://assetmemo.bio/drug/hs-10522#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
